Literature DB >> 14994142

Incidentally found medullary thyroid cancer: treatment rationale for small tumors.

Andreas Raffel1, Kenko Cupisti, Markus Krausch, Achim Wolf, Klaus-Martin Schulte, Hans-Dietrich Röher.   

Abstract

The object of this study was to assess the extent of surgery required for small sporadic medullary thyroid cancers (sMTCs). We retrospectively studied 261 patients with MTCs treated in our institution between 1986 and 2002 and identified 15 patients with small pT1 or pT2 sMTCs. The tumors were diagnosed incidentally, so surgical therapy was less than total thyroidectomy. Total thyroidectomy with or without neck dissection was applied to all other patients as standard surgical treatment of care. Patients were systematically followed up by postoperative ultrasonography, calcitonin, carcinoembryonic antigen levels, and pentagastrin stimulation tests. On long-term follow-up over a period of 4.6 years, the rate of biochemical cure in these patients who underwent less than total thyroidectomy for a sporadic incidentally diagnosed tumor was 100%. We concluded that completion thyroidectomy and neck dissection are not mandatory in patients in whom a solitary small sMTC is incidentally discovered by histologic diagnosis following operation so long as a genetic background is excluded. Nevertheless, such patients require systematic careful long-term follow-up.

Entities:  

Mesh:

Year:  2004        PMID: 14994142     DOI: 10.1007/s00268-003-7121-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  30 in total

Review 1.  Current diagnosis and management of medullary thyroid carcinoma.

Authors:  D Giuffrida; H Gharib
Journal:  Ann Oncol       Date:  1998-07       Impact factor: 32.976

2.  C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.

Authors:  K Kaserer; C Scheuba; N Neuhold; A Weinhäusel; H Vierhapper; O A Haas; B Niederle
Journal:  Am J Surg Pathol       Date:  1998-06       Impact factor: 6.394

3.  Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.

Authors:  O Gimm; J Ukkat; H Dralle
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

4.  Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.

Authors:  F Pacini; M Fontanelli; L Fugazzola; R Elisei; C Romei; G Di Coscio; P Miccoli; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1994-04       Impact factor: 5.958

5.  A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.

Authors:  I Berndt; M Reuter; B Saller; K Frank-Raue; P Groth; M Grussendorf; F Raue; M M Ritter; W Höppner
Journal:  J Clin Endocrinol Metab       Date:  1998-03       Impact factor: 5.958

6.  Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified?

Authors:  O Gimm; H Dralle
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

7.  Surgical reintervention for differentiated thyroid cancer.

Authors:  P E Goretzki; D Simon; A Frilling; J Witte; C Reiners; M Grussendorf; F A Horster; H D Röher
Journal:  Br J Surg       Date:  1993-08       Impact factor: 6.939

8.  Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases.

Authors:  N Beressi; J M Campos; J P Beressi; B Franc; P Niccoli-Sire; B Conte-Devolx; A Murat; P Caron; L Baldet; J L Kraimps; R Cohen; J C Bigorgne; O Chabre; P Lecomte; E Modigliani
Journal:  Thyroid       Date:  1998-11       Impact factor: 6.568

9.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

10.  Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.

Authors:  M F Saad; N G Ordonez; R K Rashid; J J Guido; C S Hill; R C Hickey; N A Samaan
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

View more
  10 in total

1.  Isthmus-preserving total bilobectomy: an adequate operation for C-cell hyperplasia.

Authors:  Robert Arnulf Wahl; Christian Vorländer; Susanne Kriener; Johanna Pedall; Martin Spitza; Martin-Leo Hansmann
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

2.  Concurrent Medullary, Papillary, and Follicular Thyroid Carcinomas and Simultaneous Cushing's Syndrome.

Authors:  Haggi Mazeh; Amir Orlev; Ido Mizrahi; David J Gross; Herbert R Freund
Journal:  Eur Thyroid J       Date:  2014-11-22

Review 3.  Medullary thyroid carcinoma--update and present management controversies.

Authors:  Mahir Al-Rawi; Malcolm H Wheeler
Journal:  Ann R Coll Surg Engl       Date:  2006-09       Impact factor: 1.891

4.  Clinicopathological Significance and Prognosis of Medullary Thyroid Microcarcinoma: A Meta-analysis.

Authors:  Jin Hwa Kim; Jung-Soo Pyo; Won Jin Cho
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

Review 5.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

6.  [Surgery of thyroid carcinoma].

Authors:  H Dralle; K Lorenz; A Machens
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

7.  Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines.

Authors:  Daqi Zhang; Carla Colombo; Hui Sun; Hoon Yub Kim; Antonella Pino; Simone De Leo; Giacomo Gazzano; Luca Persani; Gianlorenzo Dionigi; Laura Fugazzola
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-11       Impact factor: 6.055

Review 8.  Sporadic medullary thyroid cancer: a systematic review and meta-analysis of clinico-pathological and mutational characteristics predicting recurrence.

Authors:  Benjamin Cosway; Jonathan Fussey; Dae Kim; James Wykes; Michael Elliott; Joel Smith
Journal:  Thyroid Res       Date:  2022-07-22

9.  Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association.

Authors:  Rossella Elisei; Cristina Romei
Journal:  Thyroid Res       Date:  2013-03-14

10.  Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer.

Authors:  Andreas Machens; Steffen Hauptmann; Henning Dralle
Journal:  World J Surg       Date:  2007-10       Impact factor: 3.282

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.